Welcome to our dedicated page for Bio Green Med Solution SEC filings (Ticker: BGMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bio Green Med Solution, Inc. filings document the company's fire safety protection and distribution business, its completed shift from the former Cyclacel Pharmaceuticals biopharmaceutical operations, and its public-company governance. Regulatory reports include 8-K disclosures for quarterly and annual results, Regulation FD releases, material agreements, warrant exchanges, and preferred-stock dividend declarations.
The filing record also covers the company's common stock and 6% Convertible Exchangeable Preferred Stock, proxy materials for annual stockholder matters, Nasdaq listing-compliance matters involving the preferred stock, and corporate history items such as the acquisition of Fitters Sdn. Bhd., the liquidation of the former U.K. subsidiary, and the sale of Plogosertib.
Bio Green Med Solution (BGMS) reported an insider transaction by Yap Kim Choy, a director and 10% owner, on 11/05/2025. The filing shows a sale of 28,540 shares of common stock at a price of $1.70 per share. Separately, the reporting person acquired 467,535 shares of common stock at $0 pursuant to a warrant exchange agreement dated November 5, 2025. Following these transactions, the reporting person directly owned 467,535 common shares.
The exchange retired warrants covering the same number of underlying shares: 218,000 Series A (exercise price $7.65), 218,000 Series B ($9.00), and 31,535 Series C ($10.20), each originally exercisable from 06/20/2025 to 06/20/2030.
Bio Green Med Solution (BGMS): A 10% owner, Ong Yee Lung, exchanged outstanding warrants for common stock. On November 5, 2025, the holder acquired 467,535 shares of common stock at $0 in a warrant exchange agreement, reported as a direct holding.
The exchange covered 218,000 Series A warrants (exercise price $7.65), 218,000 Series B warrants ($9), and 31,535 Series C warrants ($10.20), each originally exercisable from June 20, 2025 to June 20, 2030. Following the transaction, the reporting person held 467,535 common shares and 0 derivative securities.
Bio Green Med Solution (BGMS) insider filed a Form 4 reporting a warrant-for-share exchange. On November 5, 2025, the reporting person acquired 467,535 shares of Common Stock (transaction code J) at $0 per share under a warrant exchange agreement.
The exchange covered 218,000 Series A warrants at $7.65, 218,000 Series B warrants at $9, and 31,535 Series C warrants at $10.2, each originally exercisable from 06/20/2025 and expiring on 06/20/2030. Following the transaction, the reporting person held 467,535 Common Stock directly and 0 derivative securities.
Bio Green Med Solution, Inc. (BGMS) reported an insider transaction. On 10/30/2025, Yap Kim Choy filed a Form 4 showing a sale of 112,260 shares of common stock at $1.807 per share (transaction code S). Following the sale, the reporting person directly owned 28,500 shares. The filing indicates direct ownership for the remaining holdings.
Bio Green Med Solution (BGMS) reported an insider transaction on a Form 4. A reporting person identified by signature as Kua Khai Loon, noted as a Director, sold 242,477 shares of Common Stock on 10/30/2025 at a price of $1.8 per share (transaction code S). Following the sale, the filing states the reporting person beneficially owned 0 shares, with ownership listed as Direct. The form indicates it was filed by one reporting person.
Bio Green Med Solution (BGMS) disclosed an insider transaction on a Form 4. On October 30, 2025, a 10% owner sold 248,814 shares of common stock (Transaction Code S) at $1.8 per share. After the sale, the reporting person held 0 shares directly.
Bio Green Med Solution (BGMS) insider transaction: A reporting person filed a Form 4 showing a sale of common stock. On 10/29/2025, the insider sold 110,749 shares of BGMS common stock at a price of $1.834 per share. Following the transaction, the filer beneficially owned 140,760 shares, held as Direct (D) ownership.
The filing indicates it was submitted by one reporting person and relates to non-derivative securities only; no derivative transactions were reported. The issuer is Bio Green Med Solution, Inc. (BGMS).
Bio Green Med Solution (BGMS) insider activity: Yap Kim Choy, a director and 10% owner, reported a sale of 13,111 shares of common stock on 10/28/2025 at $1.828 per share (transaction code S). Following the transaction, he beneficially owned 251,509 shares, held directly. This update was disclosed on Form 4.
Bio Green Med Solution (BGMS) insider filing reports that director and 10% owner Yap Kim Choy sold 120,250 shares of common stock at $2.118 on 10/27/2025.
Following the sale, the filing shows 264,620 shares beneficially owned with direct ownership.
Bio Green Med Solution (BGMS) reported a Form 4 insider transaction showing a sale of 19,858 shares of common stock at $1.99 on October 24, 2025 (transaction code S).
Following the sale, the reporting person beneficially owned 248,814 shares, held directly.